ArticleBMC public health2025
Incident cases and healthcare costs of non-communicable diseases attributable to industrialized and total sugar sweetened beverage intake in Mexico.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo estimate incident cases and healthcare costs of non-communicable chronic diseases (NCD) attributable to sugar-sweetened beverages (SSB) intake in Mexican adults.
methodsWe estimated the population attributable fractions (PAF) of NCDs- including obesity, hypertension, type-2 diabetes, cardiovascular diseases and diet-related cancers- and healthcare costs attributable to the consumption of industrialized and all SSBs. Association measures for SSB-NCD were obtained from published literature. Data on SSB intake were obtained from the 2018 Mexican National Health and Nutrition Survey (ENSANUT), incident cases of NCDs from health registries, and annual NCDs healthcare costs from Mexican studies.
resultsIndustrialized SSB intake contributed to 11.3% of obesity, 10.4% of hypertension, 17.4% of type-2 diabetes, 3.9% of cardiovascular disease, and 12.8% of diet-related cancers (PAFs are disease-specific and not additive due to multimorbidity), resulting in an annual excess healthcare cost of 202 million USD.
conclusionsDespite efforts to reduce SSB consumption, their consumption continues to affect population health and increase healthcare costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.